Search This Blog

Thursday, November 7, 2019

BridgeBio Pharma EPS beats by $0.04

BridgeBio Pharma (NASDAQ:BBIO): Q3 GAAP EPS of -$0.51 beats by $0.04.
Cash, cash equivalents and marketable securities of $446.1M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)